OWLT
Owlet, Inc.
NYSE · USHealthcareMedical - Devices
$5.64+0.71%
Price as of Jul 20, 2026
OWLT growth
Owlet, Inc. growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- +26.8%
- EBITDA
- —
- EBIT
- +35.2%
- EPS
- —
- Free cash flow
- +23.6%
- Operating cash flow
- +28.0%
Forward estimates
- Revenue
- +33.4%
- EBITDA
- -52.1%
- EPS
- +99.7%
Three-year CAGR
- Revenue
- +15.2%
- EBITDA
- —
- EBIT
- +59.1%
- Net income
- —
- EPS
- —
- Free cash flow
- +7.6%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.